Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Parker

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Annals of Internal Medicine|January 5, 2002
Caring for patients at the end of life: reflections after 12 years of practiceRichard A Parker
Trials|September 10, 2023
The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023Richard A Parker
Clinical Trials (London, England)|November 24, 2020
Commentary on Willan & Thabane: Bayesian methods are valuable in pilot trials but the choice of prior needs careful considerationRichard A Parker
Trials|March 2, 2024
Response to Letter from Wong on determining the target difference in sample size calculations for randomised controlled trialsJonathan A Cook, Richard A Parker
Trials|August 4, 2023
The importance of clinical importance when determining the target difference in sample size calculationsRichard A Parker, Jonathan A Cook
Clinical Trials (London, England)|July 16, 2020
Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justificationRichard A Parker, Christopher J Weir
JAMA|February 28, 2002
A 45-year-old woman with obsessive-compulsive disorder, 1 year laterRichard A Parker, Erin E Hartman
JAMA|February 2, 2002
An 8-year-old boy with autism, 1 year laterRichard A Parker, Erin E Hartman
Trials|January 11, 2022
Multiple secondary outcome analyses: precise interpretation is importantRichard A Parker, Christopher J Weir
JAMA|September 11, 2025
Dexmedetomidine- or Clonidine-Based Sedation vs Propofol in Critically Ill Patients-ReplyTimothy S Walsh, Richard A Parker, Christopher J Weir
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Annals of Internal Medicine|January 5, 2002
Caring for patients at the end of life: reflections after 12 years of practiceRichard A Parker
Trials|September 10, 2023
The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023Richard A Parker
Clinical Trials (London, England)|November 24, 2020
Commentary on Willan & Thabane: Bayesian methods are valuable in pilot trials but the choice of prior needs careful considerationRichard A Parker
Trials|March 2, 2024
Response to Letter from Wong on determining the target difference in sample size calculations for randomised controlled trialsJonathan A Cook, Richard A Parker
Trials|August 4, 2023
The importance of clinical importance when determining the target difference in sample size calculationsRichard A Parker, Jonathan A Cook
Clinical Trials (London, England)|July 16, 2020
Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justificationRichard A Parker, Christopher J Weir
JAMA|February 28, 2002
A 45-year-old woman with obsessive-compulsive disorder, 1 year laterRichard A Parker, Erin E Hartman
JAMA|February 2, 2002
An 8-year-old boy with autism, 1 year laterRichard A Parker, Erin E Hartman
Trials|January 11, 2022
Multiple secondary outcome analyses: precise interpretation is importantRichard A Parker, Christopher J Weir
JAMA|September 11, 2025
Dexmedetomidine- or Clonidine-Based Sedation vs Propofol in Critically Ill Patients-ReplyTimothy S Walsh, Richard A Parker, Christopher J Weir
Pageof 10